Jacobson Pharma Corporation Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
4.38 | 35.42 | -87.64% | 7.79 | -43.79% |
| P/S |
|
0.796 | 7.59 | -89.51% |
|
|
| P/BV |
|
0.4875 | 3.68 | -86.77% |
|
|
| P/FCF |
|
5.21 | 55.3 | -90.57% |
|
|
| Ev/Ebitda |
|
5.56 | 2.91 | 91.07% |
|
|
| Ev/S |
|
0.9956 | 23.72 | -95.8% |
|
|
| Ev/FCF |
|
4.12 | 63.78 | -93.54% |
|
|
| E/P |
|
0.1443 | 0.0326 | 342.22% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
7/10
|
22.8 | -11.9 | -291.57% | 22.59 | +0.9408% |
| ROE |
|
10.45 | 5.19 | 101.51% |
|
|
| ROA |
|
6.02 | 3.47 | 73.55% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
18.19 | -11.49 | -258.35% |
|
|
| ROCE |
|
7.41 | 6.04 | 22.66% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
7/10
|
1.73 | 0.7755 | 123.26% | 3.11 | -44.4% |
| Nеt Debt/Ebitda |
|
0.7197 | 0.0127 | 5552.76% |
|
|
| Debt/Ratio |
|
0.2022 | 0.1229 | 64.58% |
|
|
| Debt/Equity |
|
0.4693 | 0.776 | -39.52% |
|
|
| Debt/Net Income |
|
2.64 | 1.76 | 50.25% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
8.72 | 5.7 | 52.99% | 5.46 | +59.81% |
| Number of years of dividend growth |
|
3 | 1.13 | 166.67% | ||
| DSI |
|
0.8571 | 0.5838 | 46.82% |
|
|
| Average dividend growth |
|
4.74 | 3.2 | 48.06% |
|
|
| Average percentage for 5 years |
|
5.46 | 4.95 | 10.18% |
|
|
| Average percentage for payments |
|
35.43 | 23.96 | 47.86% |
|
|
| Difference from average difference in sector |
|
3.02 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-6.6 | 28.69 | -123% | ||
| Growth impulse Ebitda in 5 years |
|
-11.22 | -40.52 | -72.31% | ||
| Growth impulse Net Income in 5 years |
|
23.81 | 94.84 | -74.89% | ||
| Growth impulse FCF in 5 years |
|
28.12 | 91.41 | -69.24% | ||
| Growth impulse EPS in 5 years |
|
34.82 | -118.14 | -129.47% |
IP Score
6.4/10
